Total Funding
75
77
Total FundingPost-IPO Equity raised
Growth Score
-16 pts
Heat Score
16 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
8369
Cytokinetics is a biopharmaceutical company developing therapies for debilitating diseases.
- Robert Blum: President & CEOPast Role: Cytokinetics, President
Ronald Vale: Co-Founder, Cytokinetics; Professor and Howard Hughes Investigator
About the Company
Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining.
